Annotation Detail for DNAH14
Basic Information
Top
| Gene Symbol: | DNAH14 ( C1orf67,DKFZp781B1548,Dnahc14,HL-18,HL18,MGC149665,MGC149666,MGC27277,MGC51214 ) |
|---|
| Gene Full Name: | dynein, axonemal, heavy chain 14 |
|---|
| Band: | 1q42.12 |
|---|
| Quick Links | Entrez ID:127602; OMIM: 603341; Uniprot ID:DYH14_HUMAN; ENSEMBL ID: ENSG00000185842; HGNC ID: 2945 |
|---|
| Relate to Another Database: |
SFARIGene;
denovo-db |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C018021 |
cobaltous chloride |
cobaltous chloride results in increased expression of DNAH14 mRNA | increases expression | 20105288
|
| D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of DNAH14 mRNA | affects cotreatment|increases expression | 17183730
|
| D008345 |
Manganese |
Manganese results in decreased expression of DNAH14 mRNA | decreases expression | 17175027
|
| C025340 |
manganese chloride |
manganese chloride results in decreased expression of DNAH14 mRNA | decreases expression | 17175027
|
| D010100 |
Oxygen |
Oxygen deficiency results in decreased expression of DNAH14 mRNA | decreases expression | 17175027
|
| D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of DNAH14 mRNA | affects cotreatment|increases expression | 17183730
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.95 | 8875741 |
| MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.25 | 19490988 |
| MESH:D055371 |
Acute Lung Injury |
|
Oxygen |
4.88 | 16759491 |
| MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.75 | 17688650 |
| MESH:D000756 |
Anemia, Sideroblastic |
|
Manganese |
12.14 | 16910769 |
| MESH:D000756 |
Anemia, Sideroblastic |
|
manganese chloride |
12.14 | 16910769 |
| MESH:D000860 |
Anoxia |
|
Oxygen |
5.52 | 20872349 |
| MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.83 | 17497229 |
| MESH:D050197 |
Atherosclerosis |
|
Oxygen |
3.97 | 16391483 |
| MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 18558336 18940202 17157402 18177632 18985861 16609825 20603192 18775368 17507914 19460635 15238991 19232924 18316065 17688650 18396377 |
| MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.21 | 20046352 17594078 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.59 | 8888407 |
| MESH:D001943 |
Breast Neoplasms |
|
Oxygen |
3.19 | 17263869 |
| MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.80 | 20734317 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 8888407 17688650 16575769 |
| MESH:D017449 |
Dermatitis, Allergic Contact |
|
cobaltous chloride |
4.44 | 15059100 11298694 16823706 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
2.24 | 19641884 1733752 |
| MESH:D004417 |
Dyspnea |
|
Oxygen |
5.35 | 20016425 |
| MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.40 | 1851702 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.57 | 17275665 3659116 |
| MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.44 | 3922381 16628512 |
| MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.07 | 20417680 18234410 |
| MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.87 | 6426943 6254150 7562514 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.71 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.53 | 3659116 |
| MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.62 | 19224547 14986274 |
| MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.41 | 16575769 |
| MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.51 | 8888407 18558336 |
| MESH:D005739 |
Gas Poisoning |
|
Oxygen |
5.74 | 20016425 |
| MESH:D005909 |
Glioblastoma |
|
Manganese |
4.11 | 17043766 |
| MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.33 | 17688650 |
| MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
5.04 | 16612254 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.19 | 16294345 17596541 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.78 | 17228818 |
| MESH:D055370 |
Lung Injury |
|
Oxygen |
4.92 | 18339021 |
| MESH:D020149 |
Manganese Poisoning |
|
Manganese |
6.04 | 19453300 16568477 16551646 |
| MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.41 | 18803445 18765137 |
| MESH:D009069 |
Movement Disorders |
|
Manganese |
5.36 | 16551646 |
| MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.35 | 8888407 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.31 | 17596541 |
| MESH:D009410 |
Nerve Degeneration |
|
Manganese |
4.51 | 16551646 |
| MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.32 | 16359493 8888407 |
| MESH:D010300 |
Parkinson Disease |
|
Manganese |
3.46 | 11181820 |
| MESH:D020734 |
Parkinsonian Disorders |
|
Manganese |
4.77 | 16140633 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.29 | 20603192 |
| MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
5.06 | 12752131 11422049 |
| MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oxygen |
4.86 | 17627322 18339021 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.53 | 19155313 |
| MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.10 | 15737665 19110320 |
| MESH:D012640 |
Seizures |
|
Valproic Acid |
2.94 | 14763951 17978042 11738929 15475178 1511512 16876388 11044598 3137016 |
| MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
4.02 | 19490988 |
| MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
5.06 | 12833885 |
| MESH:D013398 |
Sudden Infant Death |
|
Oxygen |
6.01 | 12563064 |
| MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.75 | 17262798 |
| MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.98 | 3119515 |
| MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.06 | 8888407 |
Related Pathway Information